GLP-1 in Finland 2026: Ozempic, KELA Coverage & Access

For type 2 diabetes management in Finland, Ozempic is well-covered under KELA, and doctors here prescribe it regularly. For weight management, the coverage picture is tighter. Here's the full breakdown for 2026.

The Finnish Healthcare Context for GLP-1

Finland reorganized its regional healthcare structure in 2023, replacing the old sairaanhoitopiiri (hospital districts) with hyvinvointialueet (wellbeing services counties). There are now 22 of these counties across Finland. This matters for GLP-1 because access, referral pathways, and sometimes reimbursement criteria can vary by county.

The national baseline is set by Fimea (Finnish Medicines Agency) approvals and KELA reimbursement decisions. The regional variation is in how quickly those pathways operate and how specialist capacity is allocated.

Ozempic: The T2D Pathway

Ozempic is approved by Fimea and covered under KELA reimbursement code 205 for diabetes medications. For T2D patients meeting prescribing criteria, this is a well-established and well-covered pathway in Finland.

Your GP (lääkäri) can prescribe Ozempic directly once a T2D diagnosis is confirmed. You do not need a specialist referral to access KELA-covered Ozempic for T2D management. This is one of the more straightforward GLP-1 access paths in the Nordics.

What you need: confirmed T2D diagnosis, HbA1c data, cardiovascular history. Bring these to your GP appointment. The conversation is routine.

Wegovy: Weight Management Access

Wegovy is approved by Fimea and available in Finland. KELA reimbursement for weight management is the more complex part.

As of 2026, broad KELA coverage for Wegovy for obesity management is limited. The public reimbursement framework for weight management medications is stricter in Finland than the T2D reimbursement. Most weight management patients accessing Wegovy in Finland pay out of pocket.

Out-of-pocket cost for Wegovy in Finland: approximately €150 to 250 per month depending on dose. At maintenance dose (2.4mg weekly), costs approach the upper end of that range.

For weight management with qualifying criteria (BMI 35+, or BMI 30+ with comorbidities), it is worth asking your GP or a specialist about whether a KELA reimbursement pathway exists for your specific situation. The criteria and county-level implementation can differ. In some wellbeing services counties, obesity specialist programs exist that may access different reimbursement frameworks.

Mounjaro in Finland

Mounjaro (tirzepatide) is registered in Finland and growing in availability. For T2D patients, it is an option your prescriber can consider. KELA reimbursement status for tirzepatide is evolving, so ask your endocrinologist or diabetologist about current coverage criteria at your consultation.

Private Clinics for GLP-1 in Finland

For weight management without qualifying for public coverage, private prescription is the practical route.

Lumina Men's Clinic (Lumina Aesthetics): already mentioned in the Finland TRT guide, Lumina handles broader metabolic health including GLP-1 prescribing. If you're already working with Lumina on a TRT protocol, GLP-1 is a natural addition to discuss.

Private weight management clinics and private GP practices in Helsinki can prescribe Wegovy and Ozempic privately. Pharmacies in Helsinki have reliable stock of both products.

How to Track Your Protocol

Weekly GLP-1 injections involve a titration schedule that runs 4 to 5 months on the standard Wegovy protocol (starting at 0.25mg, reaching 2.4mg maintenance). Tracking each dose tier, your weight trend, and side effects at each level tells you how you're responding and gives your prescriber useful data.

Use the GLP-1 Dose Calculator to map out your full titration schedule from starting dose to maintenance dose and calculate per-dose volumes.

Ready to track your protocol?

• Smart reminders so you never miss a dose
• Progress tracking with photos and weight
• Medication level curves for every compound

Get Regimen Free

Related Finland Guides

If you're also on or exploring TRT in Finland, see our full Finland TRT Guide for KELA coverage, medications, and access. For peptides in Finland, see the Finland Peptides Guide.

Frequently Asked Questions

Is Ozempic covered by KELA in Finland?
Yes. Ozempic is covered under KELA reimbursement code 205 for T2D patients meeting standard prescribing criteria. Your GP can prescribe it directly without a specialist referral for T2D management.

Is Wegovy available in Finland?
Yes. Wegovy is Fimea-approved and available in Finland. Broad KELA coverage for weight management is limited as of 2026. Most weight management patients pay out of pocket at approximately €150 to 250 per month.

How much does Wegovy cost in Finland without KELA coverage?
Approximately €150 to 250 per month depending on dose. Private prescription through a GP or private weight management clinic is straightforward to obtain. Pharmacies in Helsinki carry reliable stock.

Can my GP prescribe Ozempic for T2D in Finland?
Yes. GPs (lääkärit) can prescribe Ozempic for T2D management directly once the diagnosis is confirmed. A specialist referral is not required for the standard T2D prescribing pathway under KELA reimbursement.

Does GLP-1 access vary by region in Finland?
Yes. Finland's 22 hyvinvointialueet (wellbeing services counties) can have different specialist capacity and referral queue times. The national Fimea approval and KELA reimbursement framework is consistent, but how quickly you move through the system can depend on your county. Urban areas, especially Helsinki, tend to have faster access.

This article is for informational purposes only and does not constitute medical advice. Discuss all treatment decisions with your healthcare provider.